Tag #Fda

Showing 1 to 12 of 215 results

abcnews.go.com

🌐 85% Global Worthiness

Sep 24, 01:16

Major Medical Groups Urge Continued Tylenol Use During Pregnancy Despite Trump Administration Claims

Major medical organizations and experts strongly recommend that pregnant women continue using acetaminophen (Tylenol) for fever and pain, refuting claims linking it to autism and urging against the potentially harmful effects of untreated fever.

Major Medical Groups Urge Continued Tylenol Use During Pregnancy Despite Trump Administration Claims

Major medical organizations and experts strongly recommend that pregnant women continue using acetaminophen (Tylenol) for fever and pain, refuting claims linking it to autism and urging against the potentially harmful effects of untreated fever.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the central conflict and recommendation regarding Tylenol use during pregnancy?

The Trump administration claimed a link between Tylenol use during pregnancy and autism, advising against its use. Major medical groups, including ACOG and SMFM, strongly refute this, citing the dangers of untreated fever during pregnancy and emphasizing acetaminophen as the safest pain reliever available for pregnant women. They recommend continued use under medical supervision.

theguardian.com

🌐 85% Global Worthiness

Sep 16, 19:24

US Health Officials to Release Data on Child Deaths Following COVID-19 Vaccination

US health officials are planning to release data on child deaths and serious side effects following COVID-19 vaccination, prompting concerns from public health experts about potential increase in anti-vaccine sentiment and reduced vaccine access.

US Health Officials to Release Data on Child Deaths Following COVID-19 Vaccination

US health officials are planning to release data on child deaths and serious side effects following COVID-19 vaccination, prompting concerns from public health experts about potential increase in anti-vaccine sentiment and reduced vaccine access.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term consequences of these actions on vaccination programs and public health?

The long-term consequences could include decreased vaccination rates for not only COVID-19 but also other vaccines like MMRV and Hepatitis B, potentially leading to outbreaks of preventable diseases. Gorski expresses concern that COVID-19 vaccines might become inaccessible within a year, and the Hepatitis B vaccine's recommendation may be revoked this week. This situation highlights a potential systemic shift towards vaccine hesitancy and reduced access to essential preventative measures.

cnn.com

🌐 85% Global Worthiness

Sep 13, 01:17

FDA to Abandon Expert Panels for Drug Review

The FDA plans to reduce its reliance on outside expert panels for drug reviews, a move criticized for decreasing transparency and public scrutiny, citing redundancy and workload as reasons.

FDA to Abandon Expert Panels for Drug Review

The FDA plans to reduce its reliance on outside expert panels for drug reviews, a move criticized for decreasing transparency and public scrutiny, citing redundancy and workload as reasons.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary impact of the FDA's decision to reduce the use of expert panels in drug reviews?

The FDA's decision to reduce its use of expert panels will decrease public transparency in drug approvals. Critics argue this move shields the agency's decisions from public scrutiny and diminishes opportunities for public comment on crucial decisions. The change also limits the ability of outside experts to question the FDA or drug companies, potentially leading to less thorough reviews.

forbes.com

🌐 85% Global Worthiness

Sep 12, 19:18

Wearable Tech Revolutionizes Clinical Trials

Medical-grade wearables are increasingly used in later-stage clinical trials, providing continuous data, improving safety detection, and streamlining trial design, driven by FDA support and patient demand for remote participation.

Wearable Tech Revolutionizes Clinical Trials

Medical-grade wearables are increasingly used in later-stage clinical trials, providing continuous data, improving safety detection, and streamlining trial design, driven by FDA support and patient demand for remote participation.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What role does FDA guidance play in the growing adoption of wearables in clinical trials?

The FDA's 2023 and 2024 guidance explicitly supports the use of validated digital health tools, including wearables, in later-stage trials, providing a regulatory framework for integrating remote data collection and decentralized trial design.

cnn.com

🌐 85% Global Worthiness

Sep 10, 04:17

Trump Administration Intensifies Scrutiny of Pharmaceutical Advertising

The Trump administration announced a crackdown on pharmaceutical advertising, aiming to increase enforcement of existing regulations, issue cease-and-desist letters, expand oversight to social media, and revise regulations to eliminate a provision that allows brief side effect summaries in ads.

Trump Administration Intensifies Scrutiny of Pharmaceutical Advertising

The Trump administration announced a crackdown on pharmaceutical advertising, aiming to increase enforcement of existing regulations, issue cease-and-desist letters, expand oversight to social media, and revise regulations to eliminate a provision that allows brief side effect summaries in ads.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the changes to advertising regulations potentially impact pharmaceutical companies and consumers?

The administration plans to eliminate a 1997 provision allowing brief side effect overviews, necessitating more extensive disclosures in advertisements. This will likely lead to longer ads and potentially reduce the number of ads, impacting companies' marketing strategies while potentially providing consumers with more comprehensive safety information.

us.cnn.com

🌐 85% Global Worthiness

Sep 6, 04:15

FDA Urges Child-Resistant Packaging for Nicotine Pouches Amid Rise in Child Exposures

The FDA is urging nicotine pouch manufacturers to adopt child-resistant packaging following a surge in accidental exposures among young children, some resulting in nicotine poisoning.

FDA Urges Child-Resistant Packaging for Nicotine Pouches Amid Rise in Child Exposures

The FDA is urging nicotine pouch manufacturers to adopt child-resistant packaging following a surge in accidental exposures among young children, some resulting in nicotine poisoning.

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary concern prompting the FDA's call for child-resistant packaging on nicotine pouches?

The FDA is concerned about the increasing number of reported nicotine pouch exposures in young children, many of which are causing nicotine poisoning. These pouches, often with appealing designs and flavors, are easily mistaken for candy.

cnnespanol.cnn.com

🌐 85% Global Worthiness

Sep 23, 04:17

Trump administration links acetaminophen use during pregnancy to autism risk, despite scientific debate

U.S. President Donald Trump announced that the FDA will notify physicians of a potential link between acetaminophen use during pregnancy and autism, although studies on this are inconclusive, causing concern among experts and the public.

Trump administration links acetaminophen use during pregnancy to autism risk, despite scientific debate

U.S. President Donald Trump announced that the FDA will notify physicians of a potential link between acetaminophen use during pregnancy and autism, although studies on this are inconclusive, causing concern among experts and the public.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term consequences of this announcement, and what further steps are being considered?

The announcement's long-term effects could include increased maternal anxiety and potentially harmful self-medication practices among pregnant women. The HHS plans a public awareness campaign and encourages doctors to use their best judgment. This situation highlights the risks of politicizing scientific issues without strong evidence and emphasizes the need for more rigorous research to understand autism's causes better.

cbsnews.com

🌐 75% Global Worthiness

Sep 16, 04:18

FDA Weighs Removing Menopause Hormone Therapy Warnings Amidst New Research

The FDA is considering removing health warnings from some menopause hormone therapy treatments following new research that suggests previous safety concerns were overstated, prompting debate among experts.

FDA Weighs Removing Menopause Hormone Therapy Warnings Amidst New Research

The FDA is considering removing health warnings from some menopause hormone therapy treatments following new research that suggests previous safety concerns were overstated, prompting debate among experts.

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key findings of recent research that contradict the 2002 Women's Health Initiative?

Recent studies highlight that the timing of hormone therapy initiation (closer to menopause onset) and dosage significantly affect risk. Unlike the 2002 study which focused on older women starting treatment much later, current research emphasizes the importance of individual risk factors and tailored treatment plans.

edition.cnn.com

🌐 85% Global Worthiness

Sep 13, 04:15

Analysis of COVID-19 Vaccine Safety Risks in Specific Populations

US health officials are reviewing data on potential COVID-19 vaccine risks in pregnant women, children, and the elderly, potentially leading to narrower vaccine recommendations for some groups.

Analysis of COVID-19 Vaccine Safety Risks in Specific Populations

US health officials are reviewing data on potential COVID-19 vaccine risks in pregnant women, children, and the elderly, potentially leading to narrower vaccine recommendations for some groups.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How are these investigations being conducted, and what data sources are used?

The FDA is examining datasets like VAERS for case reports of adverse events, including congenital deformities in babies born to vaccinated mothers. The CDC is also presenting data on child deaths following vaccination. However, concerns exist that VAERS is not designed to establish causality, and existing data showing no increased risks from other studies are being overlooked.

us.cnn.com

🌐 85% Global Worthiness

Sep 10, 04:17

Trump Administration to Crack Down on Pharmaceutical Ads

The Trump administration is intensifying scrutiny of pharmaceutical advertising on TV and social media, citing misleading information and insufficient safety disclosures, issuing hundreds of enforcement letters and planning new regulations to curb deceptive practices.

Trump Administration to Crack Down on Pharmaceutical Ads

The Trump administration is intensifying scrutiny of pharmaceutical advertising on TV and social media, citing misleading information and insufficient safety disclosures, issuing hundreds of enforcement letters and planning new regulations to curb deceptive practices.

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the new regulations potentially impact pharmaceutical advertising practices and spending?

The administration plans to eliminate a 1997 provision allowing brief side effect summaries in ads, requiring far more extensive disclosures. This is expected to lengthen ads and potentially decrease their frequency, impacting the $5.15 billion spent on national TV ads in 2024 and the nearly $3 billion spent in the first half of 2025.

cnn.com

🌐 85% Global Worthiness

Sep 6, 04:15

FDA Urges Child-Resistant Packaging for Nicotine Pouches Amid Rise in Child Exposures

The FDA is urging nicotine pouch manufacturers to use child-resistant packaging following a rise in accidental nicotine pouch exposures among young children, many resulting in nicotine poisoning.

FDA Urges Child-Resistant Packaging for Nicotine Pouches Amid Rise in Child Exposures

The FDA is urging nicotine pouch manufacturers to use child-resistant packaging following a rise in accidental nicotine pouch exposures among young children, many resulting in nicotine poisoning.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the broader implications and potential future actions to address this issue?

The rise in nicotine pouch use among youth is alarming, nearly doubling among high schoolers from 1.3% to 2.4% between 2023 and 2024. The FDA's actions could set a precedent for stricter packaging regulations for other potentially harmful products. Ensuring only authorized products with child-resistant packaging are available would significantly reduce accidental exposures.

theguardian.com

🌐 85% Global Worthiness

Sep 2, 22:21

Stratus" Covid-19 Variant Prompts US Vaccine Restrictions

In 2025, the US FDA approved updated Covid-19 vaccines for adults 65+ and those with high-risk conditions, prompting concerns about access and potential outbreaks due to the spread of the "Stratus" variant.

Stratus" Covid-19 Variant Prompts US Vaccine Restrictions

In 2025, the US FDA approved updated Covid-19 vaccines for adults 65+ and those with high-risk conditions, prompting concerns about access and potential outbreaks due to the spread of the "Stratus" variant.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the new vaccine restrictions impact vaccination rates and public health?

The restrictions could lead to lower vaccination rates, potentially causing larger and more severe Covid-19 outbreaks. Insurance often won't cover off-label vaccine use for those not meeting the new criteria, and pharmacies face limitations in administering vaccines without CDC recommendations.

Showing 1 to 12 of 215 results